Clinical Dilemmas for the Diagnosis and Treatment of Helicobacter pylori Infection in Children: From Guideline to Practice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Helicobacter pylori infection is often acquired in early childhood. While most infected children remain asymptomatic, H. pylori can cause chronic gastritis, gastric ulceration, and, in the long term, gastric cancer. This article aimed to review different diagnostic and treatment options and discuss the challenges associated with applying the current guidelines in the real world. Relevant articles published from 2015 to August 2023 in the English language in PubMed and Medline electronic databases were extracted using subject headings and keywords of interest to the topic. References of interest in the selected articles were also considered. Invasive and noninvasive diagnostic tests have advantages but also disadvantages and limitations according to the clinical setting and age of the child. Guidelines recommend not performing diagnostic testing in children with long-lasting or recurrent abdominal complaints or cases of a family history of severe disease caused by H. pylori. However, parents regularly consult with the explicit demand to test for H. pylori because of them or a close family member experiencing severe gastric disease caused by H. pylori. In some situations, it may be challenging for the healthcare professional to stick to evidence-based guidelines and not consider “patient-centered care,” with the risk of putting a trustful relationship in danger. Physicians may find it challenging not to perform diagnostic tests for H. pylori and prescribe eradication treatment in specific clinical settings when maintaining a trusting patient-physician relationship by applying this “patient-centered care” method when evidence-based guidelines recommend differently.
Abstract
Helicobacter pylori infection is often acquired in early childhood. While most infected children remain asymptomatic, H. pylori can cause chronic gastritis, gastric ulceration, and, in the long term, gastric cancer. This article aimed to review different diagnostic and treatment options and discuss the challenges associated with applying the current guidelines in the real world. Relevant articles published from 2015 to August 2023 in the English language in PubMed and Medline electronic databases were extracted using subject headings and keywords of interest to the topic. References of interest in the selected articles were also considered. Invasive and noninvasive diagnostic tests have advantages but also disadvantages and limitations according to the clinical setting and age of the child. Guidelines recommend not performing diagnostic testing in children with long-lasting or recurrent abdominal complaints or cases of a family history of severe disease caused by H. pylori. However, parents regularly consult with the explicit demand to test for H. pylori because of them or a close family member experiencing severe gastric disease caused by H. pylori. In some situations, it may be challenging for the healthcare professional to stick to evidence-based guidelines and not consider “patient-centered care,” with the risk of putting a trustful relationship in danger. Physicians may find it challenging not to perform diagnostic tests for H. pylori and prescribe eradication treatment in specific clinical settings when maintaining a trusting patient-physician relationship by applying this “patient-centered care” method when evidence-based guidelines recommend differently.
참고문헌 (34)
- Kusters JG, "Pathogenesis of Helicobacter pylori infection", Clin Microbiol Rev, 19, pp.449~490 (2006)
- Zamani M, "Systematic review with meta-analysis : the worldwide prevalence of Helicobacter pylori infection", Aliment Pharmacol Ther, 47, pp.868~876 (2018)
- Jones NL, "Joint ESPGHAN", NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents(update 2016), 2017, pp.64, 991~1003
- Oliveros-Bastidas A, "Human gastric cancer, Helicobacter pylori and bracken carcinogens : a connecting hypothesis", Med Hypotheses, 88, pp.91~99 (2016)
- Amieva M, "Pathobiology of Helicobacter pylori-induced gastric cancer", Gastroenterology, 150, pp.64~78 (2016)
- Wroblewski LE, "Helicobacter pylori and gastric cancer : factors that modulate disease risk", Clin Microbiol Rev, 23, pp.713~739 (2010)
- "Ned Tijdschr Geneeskd", 2005, 1326~1329
- Mourad-Baars PE, "Low antibiotic resistance of Helicobacter pylori in the Netherlands", Helicobacter, 20, pp.69~70 (2015)
- Sierra MS, "What do we know about benefits of H. pylori treatment in childhood?", Gut Microbes, 4, pp.549~567 (2013)
- Reust CE, "Recurrent abdominal pain in children", Am Fam Physician, 97, pp.785~793 (2018)
- Møller H, "Working group report on schistosomes, liver flukes and Helicobacter pylori", Int J Cancer, 60, pp.587~589 (1995)
- Koletzko S, "Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children", J Pediatr Gastroenterol Nutr, 53, pp.230~243 (2011)
- Hirpa M, "What matters to patients? A timely question for value-based care", PLoS One, 15, pp.e0227845~ (2020)
- Gluyas H, "Patient-centred care : improving healthcare outcomes", Nurs Stand, 30, pp.50~57 (2015)
- Yang JC, "Treatment of Helicobacter pylori infection : current status and future concepts", World J Gastroenterol, 20, pp.5283~5293 (2014)
- Graham DY, "Helicobacter pylori treatment in the era of increasing antibiotic resistance", Gut, 59, pp.1143~1153 (2010)
- Mehrabani S, "Helicobacter pylori infection in children : a comprehensive review", Maedica(Bucur), 14, pp.292~297 (2019)
- Liang B, "Current and future perspectives for Helicobacter pylori treatment and management : from antibiotics to probiotics", Front Cell Infect Microbiol, 12, pp.1042070~ (2022)
- Imrie C, "Is Helicobacter pylori infection in childhood a risk factor for gastric cancer?", Pediatrics, 107, pp.373~380 (2001)
- Peng C, "Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations", Chronic Dis Transl Med, 5, pp.243~251 (2020)
- Rosen R, "Pediatric gastroesophageal reflux clinical practice guidelines : joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutrition", J Pediatr Gastroenterol Nutr, 66, pp.516~554 (2018)
- Vandenplas Y, "Pediatric gastroesophageal reflux clinical practice guidelines : joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition(NASPGHAN)and the European society for pediatric gastroenterology, hepatology, and nutrition(ESPGHAN)", J Pediatr Gastroenterol Nutr, 49, pp.498~547 (2009)
- Homan M, "Are probiotics useful in Helicobacter pylori eradication?", World J Gastroenterol, 21, pp.10644~10653 (2015)
- Zhang MM, "Probiotics in Helicobacter pylori eradication therapy : a systematic review and meta-analysis", World J Gastroenterol, 21, pp.4345~4357 (2015)
- Lionetti E, "Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children : a randomized placebo controlled trial", Aliment Pharmacol Ther, 24, pp.1461~1468 (2006)
- Szajewska H, "Randomized, double-blind, placebo-controlled trial : effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children", J Pediatr Gastroenterol Nutr, 48, pp.431~436 (2009)
- Ojetti V, "Impact of Lactobacillus reuteri supplementation on anti-Helicobacter pylori levofloxacin-based second-line therapy", Gastroenterol Res Pract, 2012, pp.740381~ (2012)
- Ahmad K, "Probiotics for the treatment of pediatric Helicobacter pylori infection : a randomized double blind clinical trial", Iran J Pediatr, 23, pp.79~84 (2013)
- Lü M, "Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication : a meta-analysis of randomized controlled trials", PLoS One, 11, pp.e0163743~ (2016)
- Armuzzi A, "The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy", Aliment Pharmacol Ther, 15, pp.163~169 (2001)
- Sabbagh P, "Diagnostic methods for Helicobacter pylori infection : ideals, options, and limitations", Eur J Clin Microbiol Infect Dis, 38, pp.55~66 (2019)
- Tindberg Y, "Helicobacter pylori infection and abdominal symptoms among Swedish school children", J Pediatr Gastroenterol Nutr, 41, pp.33~38 (2005)
- Kalach N, "Helicobacter pylori infection is not associated with specific symptoms in nonulcer-dyspeptic children", Pediatrics, 115, pp.17~21 (2005)
- Kotilea K, "Helicobacter pylori infection in pediatric patients : update on diagnosis and eradication strategies", Paediatr Drugs, 20, pp.337~351 (2018)